When breast cancer patients undergo tumour ectomy, one of the most important concerns is how long they can live. However, there is no simple answer to this question, as the survival of breast cancer patients is affected by a combination of factors.
The tumour period. The tumour period is a key factor influencing the lifetime. In the case of early breast cancers, such as smaller tumours, no lymphoma transfer and long-distance transfer, the patient ‘ s prognosis is usually very good after tumour removal. Early breast cancer patients have a survival rate of up to 90 per cent or higher over a five-year period, and many are able to live long-term, as normal people do.
For breast cancer in the medium term, there may already be lymphocyte transfer and after tumour removal, there is a need for complementary treatments such as decomposition, chemotherapy, endocrine treatment or target-oriented treatment. In the medium term, the five-year survival rate of patients will drop, at around 50 to 70 per cent, but active treatment can still effectively prolong life.
Late-stage breast cancers, i.e., long-range transfers, such as to the lung, liver, bones, etc., have occurred, and even if the primary tumour of the breast is removed, the prognosis is relatively poor. However, with the emergence of new treatments, the survival of late-stage patients is gradually being extended, and some can survive for several years.
There are several pathological types of breast cancer in which leaching catheter cancer is most common. Like the in situ cancer of the catheter, if the tumour can be fully removed, the patient has a high cure rate. Some specific types of breast cancer, such as triple breast cancer, are not sensitive to endocrine treatment and target-oriented treatment, with relatively poor prognosis and may have an impact on the survival period, while the use of HeR-2 positive breast cancer, if targeted at Her-2, can significantly improve the survival of patients.
Treatment programmes Standardized and individualized treatment programmes are essential for survival. In addition to surgical removal of tumours, post-operative assisted treatment is essential. For example, chemotherapy can kill cancer cells that may be left behind; it can reduce the risk of local recurrence; endocrine treatment can be applied to hormonal receptor-positive patients and can inhibit cancer cell growth; and target-oriented treatment can provide precision for cancer cells that are genetically abnormal. The duration of life is more secure if the patient is able to receive his or her own treatment on time and in accordance with the procedure. The patient’s own condition, the age of the patient, the overall state of health of the body, also affects the duration of life. In general, young, well-healthed patients may be more resistant to treatment and recover faster. If the patient himself has other serious underlying diseases, such as heart disease, diabetes, etc., this may affect the delivery and recovery of treatment, and thus have some impact on the duration of life. Lifestyles and psychological factors Healthy lifestyles help to prolong life. Maintaining a balanced diet, eating more fruits and vegetables, proper exercise and absconding alcohol are all good for physical recovery. At the same time, the positive psychological state cannot be ignored. After the surgery, breast cancer patients have a positive effect on the body ‘ s immunity and survival if they remain optimistic and actively face disease and life. There is no fixed answer to breast cancer tumours that can survive for several years. Patients should work closely with doctors, receive standard treatment, maintain a good life and psychological state, and actively fight disease for a longer life and better quality of life. Every patient has his or her own unique situation, and should move forward with hope.
Breast cancer
